Zydus Cadila gets USFDA nod for anti-cholesterol drug Industry-The Economic Times — April 26, 2017 comments off The company has received final approval from the US Food and Drug Administration (USFDA) to market the product, Zydus Cadila said in a statement.
The company has received final approval from the US Food and Drug Administration (USFDA) to market the product, Zydus Cadila said in a statement.